tirzepatide pregnancy use Tirzepatide, Mounjaro, Period Changes and tirzepatide pregnancy safety guidelines At
Description
Repeated cycling between cold and warm environments can affect the medication's stability and effectiveness
Patients should never discontinue Mounjaro without medical guidance due to skin concerns alone, as the medication provides important therapeutic benefits for diabetes management or weight control
Your care is reviewed by Dr
The SURPASS-2 trial (PubMed ID 34170647) reported greater HbA1c reductions with tirzepatide versus semaglutide 1 mg in type 2 diabetes cohorts, while SURMOUNT-1 (PubMed ID 35658024) documented substantial body-weight reductions versus placebo in obesity cohorts
The SURPASS trials were neither designed nor powered to assess the differential efficacy of tirzepatide between these subgroups of participants
